Filing Flows › Microbot Medical (MBOT) › Q1 2026
Microbot Medical (MBOT) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
Microbot Medical (MBOT) reported revenue of $105K for the first quarter 2026 (Q1 2026).
Microbot Medical, Q1 2026: revenue $105K, net loss $3.7M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $105K | — | — |
| Operating profit | −$4.3M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$5.1M | — | — |
What changed
Revenue was $105K in Q1 2026.
Gross margin was 1.9%. Operating costs exceeded revenue by $4.3M, an operating margin of -4114.3%. The quarter ended with a net loss of $3.7M.
Operating cash flow was −$5.1M. Non-cash charges added back $12K of depreciation and amortization and $222K of share-based compensation. Working capital and other items used $1.6M. Capital expenditures of $108K exceeded it, leaving free cash flow of −$5.2M.
Questions
What was Microbot Medical's revenue in the first quarter 2026?
Microbot Medical (MBOT) reported revenue of $105K for the first quarter 2026 (Q1 2026).
Source: Microbot Medical 10-Q on SEC EDGAR.